Literature DB >> 31976448

The Utility of Operant Conditioning to Address Poverty and Drug Addiction.

Kenneth Silverman1, August F Holtyn1, Forrest Toegel1.   

Abstract

Poverty is associated with poor health. This article reviews research on proximal and distal operant interventions to address drug addiction and poverty. Proximal interventions promote health behaviors directly. Abstinence reinforcement, a common proximal intervention for the treatment of drug addiction, can be effective. Manipulating familiar parameters of operant conditioning can improve the effectiveness of abstinence reinforcement. Increasing reinforcement magnitude can increase the proportion of individuals that respond to abstinence reinforcement, arranging long-term exposure to abstinence reinforcement can prevent relapse, and arranging abstinence reinforcement sequentially across drugs can promote abstinence from multiple drugs. Distal interventions reduce risk factors that underlie poor health and may have an indirect beneficial effect on health. In the case of poverty, distal interventions seek to move people out of poverty. The therapeutic workplace includes both proximal and distal interventions to treat drug addiction and poverty. In the therapeutic workplace, participants earn stipends or wages to work. The therapeutic workplace uses employment-based reinforcement in which participants are required to provide drug-free urine samples or take scheduled doses of addiction medications to work and/or maintain maximum pay. The therapeutic workplace has two phases, a training and an employment phase. Special contingencies appear required to promote skill development during the training phase, employment-based reinforcement can promote abstinence from heroin and cocaine and adherence to naltrexone, and the therapeutic workplace can increase employment. Behavior analysts are well-suited to address both poverty and drug addiction using operant interventions like the therapeutic workplace. © Association for Behavior Analysis International 2019.

Entities:  

Keywords:  Drug addiction; Employment; Incentives; Operant conditioning; Poverty; Therapeutic workplace

Year:  2019        PMID: 31976448      PMCID: PMC6768936          DOI: 10.1007/s40614-019-00203-4

Source DB:  PubMed          Journal:  Perspect Behav Sci        ISSN: 2520-8969


  70 in total

1.  Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients.

Authors:  Stephen T Higgins; Sarah H Heil; Robert Dantona; Robert Donham; Martha Matthews; Gary J Badger
Journal:  Addiction       Date:  2007-02       Impact factor: 6.526

2.  A randomized clinical trial of a Therapeutic Workplace for chronically unemployed, homeless, alcohol-dependent adults.

Authors:  Mikhail N Koffarnus; Conrad J Wong; Karly Diemer; Mick Needham; Jacqueline Hampton; Michael Fingerhood; Dace S Svikis; George E Bigelow; Kenneth Silverman
Journal:  Alcohol Alcohol       Date:  2011-05-27       Impact factor: 2.826

3.  Evaluation of a Computer-Based HIV Education Program for Adults Living with HIV.

Authors:  Shrinidhi Subramaniam; Carol-Ann Getty; August F Holtyn; Andrew Rodewald; Brian Katz; Brantley P Jarvis; Jeannie-Marie S Leoutsakos; Michael Fingerhood; Kenneth Silverman
Journal:  AIDS Behav       Date:  2019-11

4.  Contingency management approaches to drug self-administration and drug abuse: efficacy and limitations.

Authors:  G E Bigelow; M L Stitzer; R R Griffiths; I A Liebson
Journal:  Addict Behav       Date:  1981       Impact factor: 3.913

5.  The brief abstinence test: voucher-based reinforcement of cocaine abstinence.

Authors:  E Robles; K Silverman; K L Preston; E J Cone; E Katz; G E Bigelow; M L Stitzer
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

6.  A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes.

Authors:  K Silverman; D Svikis; E Robles; M L Stitzer; G E Bigelow
Journal:  Exp Clin Psychopharmacol       Date:  2001-02       Impact factor: 3.157

7.  A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes.

Authors:  Kenneth Silverman; Dace Svikis; Conrad J Wong; Jacqueline Hampton; Maxine L Stitzer; George E Bigelow
Journal:  Exp Clin Psychopharmacol       Date:  2002-08       Impact factor: 3.157

8.  Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program.

Authors:  K Silverman; M A Chutuape; G E Bigelow; M L Stitzer
Journal:  Drug Alcohol Depend       Date:  1996-07       Impact factor: 4.492

9.  Effects of voucher-based incentives on abstinence from cigarette smoking and fetal growth among pregnant women.

Authors:  Sarah H Heil; Stephen T Higgins; Ira M Bernstein; Laura J Solomon; Randall E Rogers; Colleen S Thomas; Gary J Badger; Mary Ellen Lynch
Journal:  Addiction       Date:  2008-06       Impact factor: 6.526

10.  A meta-analytic review of psychosocial interventions for substance use disorders.

Authors:  Lissa Dutra; Georgia Stathopoulou; Shawnee L Basden; Teresa M Leyro; Mark B Powers; Michael W Otto
Journal:  Am J Psychiatry       Date:  2008-01-15       Impact factor: 18.112

View more
  10 in total

1.  Abstinence-contingent wage supplements to promote drug abstinence and employment: Post-intervention outcomes.

Authors:  Matthew D Novak; August F Holtyn; Forrest Toegel; Jeannie-Marie Leoutsakos; Kenneth Silverman
Journal:  Drug Alcohol Depend       Date:  2022-01-20       Impact factor: 4.492

2.  Effects of time-based administration of abstinence reinforcement targeting opiate and cocaine use.

Authors:  Forrest Toegel; August F Holtyn; Shrinidhi Subramaniam; Kenneth Silverman
Journal:  J Appl Behav Anal       Date:  2020-04-06

3.  Abstinence-contingent wage supplements to promote drug abstinence and employment: a randomised controlled trial.

Authors:  August F Holtyn; Forrest Toegel; Shrinidhi Subramaniam; Brantley P Jarvis; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman
Journal:  J Epidemiol Community Health       Date:  2020-02-21       Impact factor: 3.710

4.  Financial incentives promote engagement in employment services for unemployed adults in treatment for opioid use disorder.

Authors:  August F Holtyn; Forrest Toegel; Shrinidhi Subramaniam; Meghan Arellano; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

5.  Relapse after incentivized choice treatment in humans: A laboratory model for studying behavior change.

Authors:  Eric A Thrailkill; José A Alcalá
Journal:  Exp Clin Psychopharmacol       Date:  2021-01-28       Impact factor: 3.157

6.  Employment outcomes of substance use disorder patients enrolled in a therapeutic workplace intervention for drug abstinence and employment.

Authors:  August F Holtyn; Forrest Toegel; Meghan Arellano; Shrinidhi Subramaniam; Kenneth Silverman
Journal:  J Subst Abuse Treat       Date:  2020-10-06

7.  Remotely delivered incentives to promote buprenorphine treatment engagement in out-of-treatment adults with opioid use disorder.

Authors:  August F Holtyn; Forrest Toegel; Matthew D Novak; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman
Journal:  Drug Alcohol Depend       Date:  2021-05-27       Impact factor: 4.852

8.  A positive psychology framework for why people use substances: Implications for treatment.

Authors:  Bryant M Stone
Journal:  Front Psychol       Date:  2022-09-28

9.  Remotely administered incentive-based treatment for alcohol use disorder with participant-funded incentives is effective but less accessible to low-income participants.

Authors:  Mikhail N Koffarnus; Anita S Kablinger; Brent A Kaplan; Elisa M Crill
Journal:  Exp Clin Psychopharmacol       Date:  2021-06-10       Impact factor: 3.157

10.  Factors associated with obtaining employment among opioid use disorder patients enrolled in a therapeutic workplace intervention.

Authors:  August F Holtyn; Forrest Toegel; Matthew D Novak; Kenneth Silverman
Journal:  Drug Alcohol Depend       Date:  2021-07-21       Impact factor: 4.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.